Premium
Mankind Pharma Ltd plans to raise over Rs 9,000 crore ($1.2 billion) through non-convertible debentures (NCDs) and .........
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
